Organization
MedImmune LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
MedImmune LLC
... 3 between 8:00am and 11:30am. Based on these preliminary results, Innate's partner AstraZeneca/MedImmune progressed the combination with standard of care therapies. About Monalizumab: Monalizumab is ...
... an important clinical collaboration on our proprietary IPH5401 program with our partner, AstraZeneca/MedImmune. We also welcomed Professor Eric Vivier to Innate Pharma as Chief Scientific ...
... AstraZeneca and MedImmune, its global biologics research and development arm, will present updates from its ...
... by HPV, including cervical, vulvar and anal precancers and with our partner MedImmune/AstraZeneca for HPV-related cancers." This open-label, multi-center Phase 2 study is designed to ...
... an important clinical collaboration on our proprietary IPH5401 program with our partner, AstraZeneca/MedImmune. We also welcomed Professor Eric Vivier to Innate Pharma as Chief Scientific ...
... roles in the early and late stages of blood vessel formation. RELATED: MedImmune and Abpro launch bispecific antibody spinout In 2016, Abpro signed a $3.5 ...
... 2 efficacy stage of the trial, triggering a milestone payment to Inovio. MedImmune is evaluating MEDI0457 in combination with durvalumab, its PD-L1 checkpoint inhibitor, in ...
... and key companies operating in this pipeline space include Johnson & Johnson, MedImmune and ReViral. There are five products in development for HPIV-3 infections and ...
... quarter of the year, we also entered into a license agreement with MedImmune, the global biologics research and development arm of AstraZeneca. With this agreement ...
... preliminary data this year. It’s also at work on mavrilimumab, an old MedImmune drug, which works as a monoclonal antibody that antagonizes the signaling of ...
Subscribe now for full coverage on MedImmune LLC
Start My Free Trial